Dr. Yelena Losev, Deputy Director of National Mycobacterium Reference Laboratory National Public Health Laboratory, Public Health Service, Ministry of Health, Israel
Yelena Losev, Ph.D., seems like an excellent candidate for the Best Researcher Award based on her impressive credentials and contributions to her field. Here’s a summary of why she would be a strong nominee:
Profile 👤🔍
Scopus
Relevant Experience 🏥🔬
Dr. Losev has a distinguished track record in public health and laboratory diagnostics, particularly in tuberculosis (TB) and mycobacteria. Her roles include Deputy Director of the National Mycobacterium Reference Laboratory and Coordinator of the Drug Resistance Field, which showcase her leadership and expertise.
Educational Background 🎓📚
With a Direct Ph.D. in Biotechnology and significant experience in research and teaching at Tel-Aviv University, she has a solid academic foundation.
Publications and Research 📝🔍
Dr. Losev has several notable publications, including studies on drug-resistant TB and Alzheimer’s disease. Her work is recognized and forthcoming in high-impact journals, reflecting her contribution to critical scientific research.
Professional Achievements 🏆🌟
Her accolades include being an Outstanding Employee and receiving invitations to speak at various conferences and workshops, further demonstrating her recognition in the field.
Teaching and Lectures 👩🏫📢
Dr. Losev has actively contributed to education through lectures and courses on TB diagnostics and laboratory methods, indicating her role in shaping the next generation of researchers and practitioners.
Overall, Dr. Losev’s extensive experience, impactful research, and active involvement in the scientific community make her a strong contender for the Best Researcher Award.
Publication Top Notes 📄✍️
Differential effects of putative N-glycosylation sites in human Tau on Alzheimer’s disease-related neurodegeneration
Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model
Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity
Integrating in vitro and in silico approaches to evaluate the “dual functionality” of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils
Altered protein glycosylation predicts Alzheimer’s disease and modulates its pathology in disease model Drosophila